thanks Misiu, sounds like things are going at a good pace. I am sure the financing is a giant pile of different options at this point. Until we have a readout on the TNBC, I don't see a financing deal at a better level and I think Nader see it this way also. The licensing of the prostrate test is possibly the key to putting some financial support behind this in the near term.
Misiu, I have to say that I am grateful that you took the time to call and patiently wait for Dr NP to call you back. What you did was what I call a true trooper in keeping us up to date on what he was able to say to you.
We all would have loved to hear the first patient injected for TNBC but we were told it might be in 1H of 2019 so since we have a great product, all one has to do is have patience for this has been a long road but we are seeing some light at the end of the tunnel - GLTU and thank you again for your investigative reporting
NP will be bubbly as always so we need to add some discounting to what he says.
TNBC - 1st patient is important to me - hopefully by end of Feb
Mono - as expected still talks with FDA - it can get delayed - have they finished 700 mg data? Do they know if they will go with 525 mg or 700 mg dosing? I expect it to slip much later than what NP is saying. Not much hope to see finish of trial in 2019